Talis Biomedical Corporation (TLIS)
OTCMKTS
· Delayed Price · Currency is USD
1.740
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $3.17 million as of March 31, 2025. Its market cap has decreased by -78.63% in one year.
Market Cap
3.17M
Enterprise Value
-37.89M
Revenue
408.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.74
Market Cap Chart
Since February 12, 2021, Talis Biomedical's market cap has decreased from 652.79M to 3.17M, a decrease of -99.51%. That is a compound annual growth rate of -72.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 21, 2025 | 3.17M | -1.08% |
| Dec 31, 2024 | 3.21M | -76.37% |
| Dec 29, 2023 | 13.57M | 13.66% |
| Dec 30, 2022 | 11.94M | -88.68% |
| Dec 31, 2021 | 105.42M | -83.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.82B |
| SS Innovations International | 1.76B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 720.71M |
| Elite Pharmaceuticals | 502.09M |
| Glass House Brands | 373.34M |
| Northwest Biotherapeutics | 318.00M |
| CytoDyn | 294.42M |